1. Home
  2. OZ vs ZURA Comparison

OZ vs ZURA Comparison

Compare OZ & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

N/A

Current Price

$50.28

Market Cap

245.7M

Sector

N/A

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.26

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZ
ZURA
Founded
2020
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
252.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OZ
ZURA
Price
$50.28
$6.26
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$11.78
AVG Volume (30 Days)
8.9K
830.1K
Earning Date
03-30-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,217,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
244.98
N/A
52 Week Low
$49.58
$0.97
52 Week High
$82.89
$6.88

Technical Indicators

Market Signals
Indicator
OZ
ZURA
Relative Strength Index (RSI) 30.92 58.88
Support Level $49.87 $5.59
Resistance Level $51.56 $6.88
Average True Range (ATR) 0.68 0.53
MACD 0.09 -0.02
Stochastic Oscillator 20.71 57.75

Price Performance

Historical Comparison
OZ
ZURA

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: